Cancer Weekly articles from June 2004

Cancer Weekly archives from June 2004

Grape seed extract and doxorubicin extinguish breast cancer cells.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Grape seed extract and doxorubicin extinguish breast carcinoma cells. According to a study from the United States, "with an approach to enhance the efficacy of chemotherapy agents against breast...

Antiestrogens and vitamin D analogues synergize to fight breast cancer.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Antiestrogens and vitamin D analogues synergize to fight breast cancer. "Development of resistance to antihormonal therapy is a major problem in the treatment of breast cancer patients. Metastatic...

Only a fraction of fetal lymphoid precursor cells are radiosensitive.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Only a fraction of fetal lymphoid precursor cells are radiosensitive. "Human fetuses are thought to be highly sensitive to radiation exposure because diagnostic low-dose X rays have been suggested...

Postsurgical mental health screenings would help head and neck cancer patients.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Postsurgical mental health screenings would help head and neck cancer patients. "The psychological needs of patients with cancer have been increasingly recognized. Those with cancers of the head and...

Permanent and temporary brachytherapy treat advanced brain cancer similarly.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Permanent and temporary brachytherapy treat advanced brain cancer similarly. According to recent research from the United States, "this study reports the initial experience at the University of...

The survivin promoter is tumor-specific in virus-mediated gene therapy.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The survivin promoter is tumor-specific in virus-mediated gene therapy. "It has been demonstrated that survivin, a novel member of the inhibitor of apoptosis (IAP) protein family, is expressed in...

Doxorubicin engenders paradoxical signals in the heart.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Doxorubicin engenders paradoxical signals in the heart. According to a study from Italy, "the cardiotoxicity induced by the anticancer anthracycline doxorubicin (DOX) is attributed to reactions...

Unknown mechanism of action involved in expression of cytokines in mast cells.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- An unknown mechanism of action is involved in the expression of cytokines in mast cells. Scientists in Japan reported, "Olopatadine hydrochloride (olopatadine) is an anti-allergic drug that...

Fas-mediated apoptosis enhanced in ageing human keratinocytes.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Fas-mediated apoptosis is enhanced in ageing human keratinocytes. "Cellular senescence and apoptosis are two metabolically related and seemingly synergistic processes that are involved in tissue...

Hedgehog-interacting protein prevents basal cell carcinoma.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Recombinant hedgehog-interacting protein provides immunoprevention of basal cell carcinomas. "Basal cell carcinomas (BCCs) are driven by abnormal hedgehog signaling and highly overexpress several...

Bothrops jararaca venom targets tumor cells and their mediators.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Bothrops jararaca venom targets tumor cells and their mediators. According to a study from Brazil, "snake venoms have been used as antineoplastic substances in several experimental models. We...

$14.9M in grants to fund research for blood cancer treatments.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The Leukemia & Lymphoma Society announced 70 Career Development Program grants totaling $14.9 million. The grants, which allow scientists at different stages of their careers to devote themselves...

Scientists show adult blood stem cells can transform into brain cells in people.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- University of Florida (UF) scientists have discovered that male blood stem cells evolved into male brain cells in three women who underwent bone marrow transplantation to treat cancer. The...

Radiation-induced activation of caspase-9 blocks glioma invasion.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Radiation-induced activation of caspase-9 blocks glioma invasion. "Glioblastoma multiforme, the most common brain tumor, typically exhibits markedly increased angiogenesis, which is crucial for...

Brochure helps patients understand radiation therapy.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- To help patients understand the importance of radiation therapy in the treatment of breast cancer, the American Society for Therapeutic Radiology and Oncology (ASTRO) has published the new patient...

Combined image guidance can be done with reduced biopsy weights.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers report a new breast biopsy technique, combined image guidance (CIG) that uses a guide-wire placed under mammographic guidance. "When mammography detects a nonpalpable lesion, the...

Cyclin D1 overexpression appears to predict tamoxifen resistance.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Overexpression of the cell-cycle regulator and estrogen-receptor alpha co-factor, cyclin D1, appears to predict tamoxifen resistance in breast cancer tumors, pathologists in Sweden report. ...

Cyclin-dependent kinase 2 activated by cyclin E in breast cancer cells.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Cyclin-dependent kinase 2 is activated by full length and low molecular weight forms of cyclin E in breast cancer cells. According to a study from the United States, "Cyclin E, a positive regulator...

Cytological and histological diagnostic markers compared.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Diagnostic markers of breast cancer detectable through cytologic and histologic tests have been identified. "Although fine-needle aspiration cytology is a routine procedure for the diagnosis of...

Diagnosis of breast cancer more difficult in obese Korean women.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The diagnosis of breast cancer is more difficult in obese Korean women. According to a study from South Korea, "This study was carried out to test the hypothesis that palpation for lumps may be more...

Imaging company announces increased second-quarter revenues.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Hologic, Inc., (HOLX), a provider of women's diagnostic imaging systems and state-of-the-art digital imaging systems, announced its results for the quarter ended March 27, 2004. Second-quarter...

Minimal residual breast cancer detected using CK19 and EGF-R primers in RT-PCR.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Minimal residual breast cancer was detected using cytokeratin 19 and epidermal growth factor receptor primers in an RT-PCR assay. "Breast cancer cells pose a difficult target for detection due to...

More research needed on adjuvant endocrine therapy of breast cancer.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- More clinical research is needed to advance knowledge of adjuvant and neoadjuvant endocrine therapy of breast cancer. "Adjuvant endocrine therapy following surgical resection of early,...

New method described to localize nonpalpable lesions with adhesive marker plate.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Radiologists in Spain have developed a way to localize nonpalpable breast lesions easily and accurately using an "adhesive marker plate that makes an anteroposterior approach to the thoracic wall...

Nuclear receptor LRH-1 regulates aromatase expression in adipose tissue.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The nuclear receptor LRH-1 regulates aromatase expression in adipose tissue. According to recent research from Australia, "Aromatase is the enzyme responsible for estrogen production, and is the...

Ovarian ablation as a treatment for breast cancer.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Ovarian ablation is an effective treatment for premenopausal women with hormone receptor positive breast cancer. "It can be achieved permanently by surgery or radiotherapy and reversibly by LhRH...

Potential for adjuvant radiotherapy doesn't sway women from reconstruction.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Even though they may need additional radiation therapy, most female breast cancer patients in a Scottish study still opted for immediate breast reconstruction surgery. Having an implant or tissue...

Protective role of fibulin-1 elucidated.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The protective role of fibulin-1 (Fbln-1) in breast cancer patients has been elucidated. According to recent research from Italy, Fbln-1 is "an immunogenic breast cancer-related glycoprotein...

Radiation improves survival in node-positive breast cancer patients.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Postmastectomy radiotherapy improves overall survival in node-positive breast cancer patients. "Postmastectomy irradiation substantially reduces the risk of locoregional recurrences (LRR) of breast...

Sentinel node biopsy accurately stages axilla in multifocal breast cancer.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- According to a study from Wales, sentinel node biopsy accurately stages axilla in multifocal breast cancer and could become another option in addition to complete axillary lymph node dissection in...

Studies describe how mutations affect BRCA1 function.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Two new structural studies reveal how mutations within the C-terminal region of the BRCA1 protein affect the function of the BRCA1 gene, leading to breast cancer. Among the 180,000 women who develop...

Study discusses the molecular biology of the estrogen receptors.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers review the newer anti-estrogens in treating breast cancer. "Evidence for a role of ovarian factors in the growth of metastatic breast cancer was first recognized over 100 years ago....

Young women fare worse in physical, psychosocial function after cancer diagnosis.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Young women may fare worse than older females in terms of physical and psychosocial function after being diagnosed with breast cancer, say Harvard University researchers. "A total of 122,969 women...

myDNA.com announces publication of breast cancer channel.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- myDNA Media, Inc., announced the publication of its breast cancer channel located within its charter website, www.myDNA.com. The myDNA.com breast cancer channel integrates multi- cultural, relevant...

Sentinel node biopsy in locally advanced breast cancer reviewed.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers review sentinel node biopsy in the era of neoadjuvant therapy and locally advanced breast cancer in a recent issue of Surgical Oncology - Oxford. According to published research from the...

Aromatase inhibitors for postmenopausal breast cancer therapy reviewed.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers review aromatase inhibitors for the treatment of postmenopausal breast cancer in a recent issue of the Journal of the American Geriatrics Society. "This article provides a comprehensive...

Enzyme inhibitor enhances the work of breast cancer adjuvant endocrine therapy.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Enzyme inhibitor enhances the work of breast cancer adjuvant endocrine therapy. According to a study from England, "the tissue inhibitors of metalloproteinases (TIMPs) control the activities of...

Gefitinib and trastuzumab show promise for treatment of metastatic breast cancer.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The combination of gefitinib and trastuzumab shows promise for the treatment of metastatic breast cancer (MBC). "Despite new therapies and several treatment options," MBC "remains incurable,"...

Novel systemic therapies for breast cancer reviewed.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers review novel systemic therapies for breast cancer in a recent issue of Surgical Oncology - Oxford. According to published research from England, "The rapid expansion in our knowledge of...

Swiss and Austrian distributor announced for Thalidomide Pharmion.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Pharmion Corporation (PHRM) has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in Switzerland and Austria. Lipomed will also act as Pharmion's distributor partner in those...

Melanocortin 4 receptor antagonist reduces tumor-induced weight loss.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- A small molecule melanocortin 4 receptor antagonist effectively reduces tumor-induced weight loss in a mouse model. According to recent research from the United States, "The melanocortin 4 receptor...

Collaboration to develop PB1 mutant IL-2 cancer therapeutic.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Pivotal BioSciences, Inc., and ProteomTech, Inc., announced their collaboration for the development of PB1, Pivotal's mutant IL-2 cancer therapeutic. PB1 is an innovative low toxicity analog of...

Heather Urich to serve as LifeRamp national spokesperson.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Ramp Corporation (RCO) announced that Heather Urich will serve as National Spokesperson for LifeRamp Family Financial, Inc. LifeRamp, a wholly-owned subsidiary of Ramp Corporation, intends to...

Soybean protein peptide may inhibit growth of tumor cells.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- American Oriental Bioengineering, Inc., announced findings that soybean protein peptide may inhibit the growth of tumor cells. Research conducted at American Oriental Bioengineering's research...

Triapine and Cloretazine trial results published in scientific journals.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc., (VION) announced that articles related to its clinical stage anticancer products, Triapine and Cloretazine (VNP40101M) have been published in scientific journals. A...

Common cancers prevail among first-degree relatives of ovarian cancer patients.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Common cancers prevail among first-degree relatives of ovarian cancer patients. "Epidemiologic studies have demonstrated a tendency for common cancers to aggregate in families. The authors...

The new asbestos amphibole fluoro-edenite is linked to Italian cancer cases.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The new asbestos amphibole fluoro-edenite is linked to Italian cancer cases. According to a study from Italy, "the aim of the present research was to determine whether the recently identified and...

Philips Lighting lawsuit set for 2005 trial.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The first trial in a mass civil lawsuit alleging a Marion County plant exposed about 1,500 former workers to cancer-causing chemicals has been set to begin September 13, 2005. The lawsuit accuses...

Breast exams could be 'teachable moment' to prompt colon cancer screening.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Many women who regularly get checked for breast cancer and cervical cancer still don't go for a test that could save them from another big killer: colon cancer, according to new University of Michigan...

"Nanobodies" herald a new era in chemotherapeutics.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Cancer, along with heart and vascular disease, is the major cause of death in the Western world. The first generation of anticancer drugs has already saved many lives, but because these medicines are...

Antisense inhibitor of methylated DNA-binding protein 2 blocks new tumors.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Antisense inhibitor of methylated DNA-binding protein 2 blocks new tumors. According to recent research from Canada, "methylated DNA-binding protein 2 (MBD2) has been proposed to function both as a...

Chemotherapy patients get Moraxella osloensis via central venous catheter.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers report that Moraxella osloensis infection was colonized via the central venous catheter in some patients undergoing chemotherapy. "Moraxella osloensis, a Gram-negative bacterium that is...

Cutting tumor supply lines may boost cancer treatments.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Scientists have long viewed the network of blood vessels tumors create to siphon oxygen and other nutrients from the body as a potential target for therapies geared toward stopping tumors in their...

Immunotherapy for cancer: Inflammations open up access to tumors.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Although the immune system potentially recognizes tumor cells as foreign and destroys them, vaccination therapies have so far been disappointing. Malignant tumors seem to establish a special...

Intensity-modulated radiotherapy appears promising for pelvic cancers.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Although Phase II results are promising, more research is needed to evaluate the safety and efficacy of intensity-modulated radiotherapy (IMRT), researchers say. "Intensity-modulated radiotherapy...

Optimal timing for catheter removal determined in candidemia patients.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The optimal timing for catheter removal after Candida infection has been determined in cancer patients. In a recent study from the United States, "[t]o determine the need and appropriate timing of...

Phase I trial with reformulated Panzem completed.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc., (ENMD), a clinical-stage biopharmaceutical company developing therapeutic candidates primarily for the treatment of cancer, announced that the company has concluded its phase I clinical...

Radiolabeled peptides rise to the challenge in the face of cancer.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Radiolabeled peptides rise to the challenge in the face of cancer. According to a study from the Netherlands, "on their plasma membranes, cells express receptor proteins with high affinity for...

Second-generation targeted antibodies - it's all in the binding.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The overproduction, or "overexpression," of the epidermal growth factor receptor (EGFR) is one of the most common aberrations in cancer, and consequently agents that inhibit EGFR are among the most...

Oklahoma Cancer treatment bill signed.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Oklahoma is no longer the only state in the nation to shun a program that uses federal Medicaid money for screening and treatment of women with breast and cervical cancer. Governor Brad Henry...

Complement function in antibody-mediated cancer immunotherapy described.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers describe complement function in monoclonal-antibody-mediated cancer immunotherapy in a recent issue of Trends in Immunology. "Complement activation by monoclonal antibodies can cause...

Current developments of immunotherapy in the clinic reviewed.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers review current developments of immunotherapy in the clinic According to published research from the United States, "The clinical application of immunotherapy for cancer is rapidly moving...

Heat shock protein 70-pulsed dendritic cells elicit tumor immunity.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity. "Vaccination with autologous tumor-derived heat shock proteins...

Plasmids costimulate DNA vaccine against carcinoembryonic antigen.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA). "Vaccination with plasmids encoding an antigen of interest (DNA...

Tumor-specific antigens are encoded by gene MAGE-C2.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Researchers report two new tumor-specific antigenic peptides that are encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2. According to a study from Belgium, "We have...

Vaccination against cervical cancer reviewed.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Scientists review vaccines against cervical cancer in a recent issue of Hospital Medicine. According to recent research from Wales, "The link between human papillomavirus (HPV) and cervical cancer...

CINtec technology granted U.S. patent for diagnosis of carcinomas.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- mtm laboratories AG, announced the granting of U.S. patent 6,709,832 entitled "Methods of Early Diagnosis of Carcinomas," covering the company's CINtec technology. mtm's CINtec technology is based...

TALL-104 cells injure glioma cells by apoptotic and necrotic pathways.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- TALL-104 cells injure glioma cells by apoptotic and necrotic pathways. "TALL-104 is a human leukemic T cell line that expresses markers characteristic of both cytotoxic T lymphocytes and natural...

Thiol depletion aids bax-induced programmed cell death in lung cancer cells.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Thiol depletion aids bax-induced programmed cell death in lung cancer cells. According to recent research from the United States, "the utility of dominant acting proapoptotic molecules to induce...

IARC Recognizes HPV testing as part of cervical cancer screening.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Digene Corporation reported that the International Agency for Research on Cancer (IARC), part of the World Health Organization, has issued an assessment of available medical technologies for screening...

WHO agency confirms efficacy of screening women 25-65 to reduce mortality.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The International Agency for Research on Cancer (IARC), the cancer research arm of the World Health Organization, says screening women ages 25-65 for cervical cancer reduces their mortality risk from...

HDCT improves cure rate of young children with medulloblastoma and stPNET tumors.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- High-dose chemotherapy improves cure rate of young children with medulloblastoma and supratentorial primitive neuroectodermal tumors. "In order to improve the dismal prognosis of patients younger...

Primary sclerosing cholangitis heightens the risk for cholangiocarcinoma.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Primary sclerosing cholangitis heightens the risk for cholangiocarcinoma. "Cholangiocarcinoma (CCA) is a dreaded complication of primary sclerosing cholangitis (PSC); however, marked variability in...

Company provides two NIH agencies with open access to cloning technologies.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Invitrogen Corp. (IVGN), a provider of essential life science technologies for disease research and drug discovery, announced that it has entered into agreement with the National Human Genome Research...

Isis announces extension of antisense cancer drug-discovery collaboration.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals (ISIS) announced the extension of its antisense drug-discovery collaboration in cancer with Eli Lilly and Co. (LLY). During this extension, Isis and Lilly will continue to...

Colorectal cancer incidence is increasing in Japan.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Trends show colorectal cancer is increasing in Japan and is now similar to the rates in the U.S., researchers say. "We examined trends of colorectal cancer incidence rates among Japanese (Miyagi...

Company launches colon cancer trial with GTI-2040.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Lorus Therapeutics, Inc., announced the initiation of a clinical trial of GTI-2040 in a novel combination with oxaliplatin and capecitabine in patients with advanced unresectable colon cancer. This...

Minilaparotomy approach useful for second colorectal cancer surgery.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The minilaparotomy approach is a minimally invasive alternative to an additional radical surgery after colonoscopic snare polypectomy for T1 colorectal cancer. "An additional resection is indicated...

New treatment options featured in colorectal cancer guidelines.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- The National Comprehensive Cancer Network (NCCN), an alliance of 19 cancer centers, announced an update of the NCCN Colorectal Clinical Practice Guidelines. NCCN's Colon, Rectal, and Anal Cancer...

Study finds minimally invasive surgery safe for GI cancer.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- When performed by experienced surgeons, minimally invasive laparoscopic surgery is a safe and effective alternative to standard open surgery for most patients with cancer that is confined to the colon....

Valproic acid modulates the synthesis of angiogenic proteins in cancer cells.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Valproic acid modulates the synthesis of angiogenic proteins in cancer cells. According to recent research published in the journal Biochemical and Biophysical Research Communications, "recent...

Women underrate risk for colon cancer, survey shows.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Women significantly underrate their risk for colon cancer and are not as concerned about the disease as they should be, according to a new Good Housekeeping survey conducted on behalf of the...

Women less likely to seek colorectal screening, specialists say.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- According to gastroenterologists in private practice in the Denver, Colorado area, women are less likely than men to seek colorectal cancer screening. Colorectal cancer is the third-leading cause of...

Alternative medicine products may interfere with radiology therapies.
June 1, 2004... 2004 JUN 1 - (NewsRx.com & NewsRx.net) -- Alternative medicine products may interfere with radiology therapies. "Complementary alternative medicines (CAMs), including food supplements, are taken widely by patients, especially those with...